Anti-TCR alpha/beta Antibody Conjugated to Biotin
CAT:
952-B2016803
Size:
50 µg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No








Anti-TCR alpha/beta Antibody Conjugated to Biotin
Description:
Anti-TCR alpha/beta Antibody Conjugated to Biotin_x000D_ Catalog number: B2016803_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 50 µg_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: 2-8°C_x000D_ Keywords: Anti-TCR α/β_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Cron RQ, Ezquerra A, Coligan JE, Houlden BA, Bluestone JA, Maloy WL. Identification of distinct T cell receptor (TCR)-gamma delta heterodimers using an anti-TCR-gamma variable region serum J Immunol. 1989 Dec 1;143(11):3769-75._x000D_ 2: Kummer U, Zengerle U, Pischel J, Trautmann B, Mailhammer R, Sidell N. Increased in vivo mitogenicity of anti-TCR/CD3 monoclonal antibody through reduced interaction with Fcgamma receptors Immunol Lett. 2001 Jan 1;75(2):153-8._x000D_ 3: Jambou F, Cohen-Kaminsky S. Immunoregulation by Vbeta specific antibodies in myasthenia gravis: mining physiological T cell homeostasis for TCR specific therapy Cell Mol Biol (Noisy-le-grand). 2003 Mar;49(2):181-92._x000D_ 4: Sitkovsky MV. Mechanistic, functional and immunopharmacological implications of biochemical studies of antigen receptor-triggered cytolytic T-lymphocyte activation Immunol Rev. 1988 Mar;103:127-60._x000D_ 5: Fitch FW, McKisic MD, Lancki DW, Gajewski TF. Differential regulation of murine T lymphocyte subsets Annu Rev Immunol. 1993;11:29-48._x000D_ 6: Kishimoto H, Kubo RT, Yorifuji H, Nakayama T, Asano Y, Tada T. Physical dissociation of the TCR-CD3 complex accompanies receptor ligation J Exp Med. 1995 Dec 1;182(6):1997-2006._x000D_ 7: Boitard C, Sempé P, Bach JF. Anti-TcR antibodies in autoimmune diseases Immunol Ser. 1993;59:167-73._x000D_ 8: Tang X, Maricic I, Kumar V. Anti-TCR antibody treatment activates a novel population of nonintestinal CD8 alpha alpha+ TCR alpha beta+ regulatory T cells and prevents experimental autoimmune encephalomyelitis J Immunol. 2007 May 15;178(10):6043-50._x000D_ 9: Carbone A, Harbeck R, Dallas A, Nemazee D, Finkel T, O'Brien R, Kubo R, Born W. Alpha beta T-lymphocyte depleted mice, a model for gamma delta T-lymphocyte functional studies Immunol Rev. 1991 Apr;120:35-50._x000D_ 10: Furtado GC, Olivares-Villagómez D, Curotto de Lafaille MA, Wensky AK, Latkowski JA, Lafaille JJ. Regulatory T cells in spontaneous autoimmune encephalomyelitis Immunol Rev. 2001 Aug;182:122-34. _x000D_ _x000D_ Products Related to Anti-TCR alpha/beta Antibody Conjugated to Biotin can be found at AntiobodiesShort Description:
Catalog Number: B2016803 (50 µg)_x000D_ Anti-TCR alpha/beta Antibody Conjugated to Biotin is a high quality antibody that specifically targets and binds to the T-cell receptor (TCR) alpha/beta complex on the surface of T cells. The antibody is conjugated to biotin, a small molecule that can be easily detected and visualized using techniques such as immunohistochemistry or flow cytometry. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_Weight:
0.15Length:
2Width:
0.5Height :
0.5CAS Number:
9007-83-4